Biochim Biophys Acta
Biochimica et Biophysica Acta
0006-3002
Elsevier Pub. Co.


2212780
17631856
BBABIO45928
10.1016/j.bbabio.2007.05.008
Review


The role of mitochondria in protection of the heart by preconditioning

Halestrap
Andrew P.

A.Halestrap@Bristol.ac.uk
⁎

Clarke
Samantha J.


Khaliulin
Igor



Department of Biochemistry and Bristol Heart Institute, University of Bristol, School of Medical Sciences, University Walk, Bristol BS8 1TD, UK

⁎
A.Halestrap@Bristol.ac.uk


8
2007

1767
8
1007
1031
23
4
2007

18
5
2007

23
5
2007


© 2007 Elsevier B.V.
2007
Elsevier B.V.
certain conditions
.


Abstract
+
 channel openers uncouple mitochondria and others inhibit respiratory chain complexes, and their ability to produce ROS and precondition hearts is mimicked by bona fide uncouplers and respiratory chain inhibitors. IP may also provide continuing protection during reperfusion by preventing a cascade of MPTP-induced ROS production followed by further MPTP opening. This phase of protection may involve survival kinase pathways such as Akt and glycogen synthase kinase 3 (GSK3) either increasing ROS removal or reducing mitochondrial ROS production.

Abbreviations
5HD, 5-hydroxydecanoate
AMPK, AMP activated protein kinase
ANT, Adenine nucleotide translocase
APD, Action potential duration
BCDH, branched chain 2-oxoacid dehydrogenase
CrK, creatine kinase
CsA, cyclosporin A
CyP, cyclophilin
Cx43, connexin43
GSK3, glycogen synthase kinase 3
IP, ischaemic preconditioning
ATP
, ATP-dependent potassium channels
ATP
, mitochondrial ATP-dependent potassium channels
MCT1, monocarboxylate transporter 1
MPTP, mitochondrial permeability transition pore
PDH, pyruvate dehydrogenase
PDK1, phosphoinositide-dependent kinase 1
PI-3-kinase, phosphatidyl inositol 3 phosphate kinase
PKC, protein kinase C
PKG, cyclic GMP-dependent protein kinase
PPi, pyrophosphate
PPIase, peptidyl-prolyl cis-trans isomerase
PTEN, Phosphatase and TENsin homolog
ROS, reactive oxygen species
SfA, Sanglifehrin A
SUR, sulphohylurea receptor
VDAC, voltage activated anion channel

Keywords
Mitochondrial permeability transition pore
Ischaemia
Reperfusion
ROS
Calcium
PKC
ATP
 channel



1
Introduction
[1–3]
[1–3]
[4]
[5,6]
. Understanding the causes of reperfusion injury and devising ways of preventing it is of major clinical importance in cardiac surgery and the treatment of coronary thrombosis.
[1,3,7–10]
[11–13]
. However, first it is necessary to explain the phenomenon of preconditioning.

2
The phenomenon of ischaemic preconditioning
[14]
[15–17]
[14,18]
[19]
[15]
[15,20–22]
Section 6
[23–25]
[25]
 and where effects on mitochondria have been demonstrated in postconditioning they will be noted.

3
Causes of reperfusion injury
2+
[1,3,9,26]
.
3.1
Damage occurring in ischaemia (Reviewed in [1;3;26])
i
+
+
i.
+
i
2+
+
2+
2+
 out of the cell, is inhibited or reversed. The conversion of ATP to ADP and AMP is rapid and reversible. AMP is slowly converted into adenosine and then inosine and xanthine through a purine degradation pathway. These nucleosides leak out of the cell (and may have vasodilator effects through purinergic receptors) and lead to a gradual depletion of adenine nucleotide which may contribute to the reduced cardiac performance (stunning) seen on reperfusion.
[27]
[26,28–31]
2+
[1,3,26,32]
[1,3]
.

3.2
Damage occurring during reperfusion
[27]
[26,28–30]
[28]
[26,31]
[33–35]
[36,37]
[38]
2+
[1,3,10,26,39]
.


4
The mitochondrial permeability transition pore (MPTP)
4.1
Properties of the MPTP
[3,40,41]
[3,9,26]
. Unless pore closure occurs, these changes will cause irreversible damage to the cell resulting in necrotic death.
[42]
[43]
c
[44,45]
.

4.2
The molecular identity of the MPTP
[40,41,46]
[46,47]
[48]
[49,50]
[51,52]
[53–55]
.
[9,56]
[57]
[57]
160
[58]
[58,59]
[60]
2+
[61]
[62]
[63]
[64]
.
[3,40,41,65]
[3,40,65]
[66]
[67]
 make an essential role for VDAC1 unlikely. See note added in proof.


5
The MPTP opening plays a central role in reperfusion injury
5.1
The MPTP opens during reperfusion but not ischaemia
3
[68]
[69]
[70,71]
c
[72]
[68]
[73]
[74]
[75]
[75]
[76–78]
+
+
[3,79,80]
[81,82]
.
[1,9]
2+
2+
[83]
[27,84]
[73]
[1,3,9,65]
[75,85]
c
Section 4.1
[5,6]
[54,55]
[46]
.

5.2
Inhibition of MPTP opening protects hearts from reperfusion injury
[86]
[68,87,88]
[88,89]
[90,91]
.
[92]
[93]
[94]
[80]
[75,95]
[75]
[75,96]
.

5.3
Protection by preconditioning involves inhibition of MPTP opening
[85]
[69,97]
[98]
[85,99,100]
[85,100]
[99–101]
Section 6
).
[101]
[102]
[101]
.


6
Signalling pathways linking preconditioning to inhibition of the MPTP
[16,30,103–107]
[30,103–107]
. Here we will only provide a brief overview before focussing on how they may exert their effects on the mitochondria.
6.1
The role of protein kinase C
[105]
[103]
[105]
[108]
[109–111]
[112–114]
[113–115]
Fig. 1
[116]
.
sections 7–10
[104]
[27,117,118]
[118–120]
[100,101,118,121]
[35,122]
 and thus provides a mechanism by which ROS could activate PKC.

6.2
The role of nitric oxide and cyclic GMP dependent protein kinase
[106,123,124]
ATP
Section 9
ATP
[123]
ATP
[125]
Sections 7
[128]
ATP
Section 10.2
.

6.3
The role of pro-survival kinases
[107,126]
[107,127]
[126,128–130]
[106,107]
.
[97]
[131]
[132]
[53]
. See note added in proof.

6.4
The role of AMP-activated protein kinase
[133]
ATP
Section 10
[133]
[134]
[135]
[136]
[101]
.
Taken together, all these data suggest that several signalling pathways may interact or act in parallel to induce IP, but the ultimate target of their action remains unclear. Since IP involves inhibition of the MPTP the signalling pathway must ultimately inhibit MPTP opening, but this could be achieved either by direct phosphorylation of a component of the MPTP or indirectly by influencing factors that enhance pore opening such as by reducing oxidative stress or calcium overload.


7
Mechanism of inhibition of the MPTP by IP
7.1
Is there evidence for regulation by phosphorylation?
[115]
[3,40]
[137]
[85,100]
[97,113,114]
Fig. 1
. A key aspect of our experiments was the use of Percoll gradient centrifugation to remove plasma membrane contamination which we have shown is significant in less pure mitochondrial fractions. This was demonstrated by the presence of monocarboxylate transporter 1 (MCT1) in the crude but not the purified mitochondria.
32
[138]
[139]
[140,141]
.
[142,143]
32
32
[139,144]
32
[145]
. Nevertheless, a lack of turnover might suggest that such a phosphorylation does not play an important role in signalling.
[142,146]
Fig. 2
. Overall, our data do not support a role for mitochondrial protein phosphorylation in mediating the inhibition of MPTP opening by IP. Rather, our data suggests that the inhibition of the MPTP by preconditioning may be secondary to either diminished ROS production or calcium overload as described below.

7.2
Effects of IP on ROS production and calcium loading during ischaemia and reperfusion as potential mediators of MPTP inhibition
[83,147]
[73]
[27,84,148,149]
[150–153]
. Thus it is quite possible to account for the IP-mediated inhibition of MPTP opening at reperfusion merely through these indirect effects without having to invoke phosphorylation of any mitochondrial protein.
[85,100]
[99–101]
[100,101]
[154]
[155,156]
 argues in favour of the latter. However, an additional effect of IP to reduce ROS production cannot be ruled out.


8
The role of mitochondrial potassium channels
ATP
[12,157]
ATP
ATP
[146]
ATP
ATP
[12,157]
[158–160]
ATP
ATP
[11,12,161–163]
ATP
ATP
 channel proposed to reside in the mitochondrial inner membrane.
8.1
+
 channels and their physiological roles
+
+
+
+
+
[43,164]
+
[12]
+
[165,166]
).

8.2
+
 channels
+
[167–171]
[172–174]
+
[168,175–179]
+
[180,181]
. However, in the majority of published work no data were presented to discount such contamination. Thus it is important to confirm that the activity of any channels identified by such techniques can be demonstrated in mitochondria, and this can be achieved by measurements of mitochondrial matrix volume.
+
+
+
+
[43,164,165,182]
+
3
2
14
[165,182]
[182]
[44,49,170,183,184]
[44,49,170,171]
.
[44,49,170,171]
[182]
[185]
[170]
[171]
Fig. 3
[170,171]
Fig. 3
[171]
+
 channels in intact mitochondria that rely entirely upon light scattering changes for measurement of matrix volume should be treated with caution. Parallel isotopic measurements of matrix volume provide an essential confirmation that such light scattering changes do reflect changes in volume rather than morphology.

8.3
ATP
 channel
+
[49,186,187]
[188]
[171]
ATP
[172]
[189]
[165,166]
ATP
Section 8.2
ATP
ATP
2+
ATP
ATP
[176,177]
[165]
[165,168,190]
ATP
ATP
ATP
[167,168]
ATP
ATP
[191–194]
.
ATP
ATP
[12]
[166,195]
[195]
[166]
125
[196]
ATP
ATP
ATP
[197]
ATP
ATP
 channel in their preparations of isolated brain mitochondria than reported in liver or heart mitochondria.
ATP
ATP
ATP
Section 8.2
ATP
[170,171]
ATP
[170,171]
ATP
ATP
Section 9.1
).

8.4
+
 channel
[182,198]
+
[182,198]
2+
[186]
[199–201]
+
[202,203]
[186]
[188]
+
[186]
[171]
.
[180,204]
[174]
Ca
Ca
Ca
Ca
Ca
.


9
+
 channels being involved in the protective mechanism of preconditioning?
9.1
The use of pharmacological agents is hampered by lack of specificity
ATP
[11,12,161–163]
[205,206]
Ca
ATP
Ca
Ca
[13,174]
Section 8.3
ATP
Ca
 channels. In the absence of independent verification of this, the conclusions drawn must be treated with caution. This is especially so in the light of increasing evidence that these agents have other non-specific effects on mitochondria including inhibition of the respiratory chain and uncoupling as is discussed below.
ATP
[169,206–209]
[210,211]
[210]
[212]
.
ATP
[206,209,213]
[206,214]
ATP
[215–217]
.
ATP
ATP
bona fide
[31,218–221]
[222]
[223,224]
ATP
 channels. Thus, in order to establish a role for mitochondrial potassium channels in ischaemic preconditioning more direct evidence for their opening during IP must be provided.

9.2
ATP
 channel activation during preconditioning
+
 channel opening is occurring during preconditioning. The first is the determination of matrix volume in situ and the second is measurement of other effects that an increase in electrogenic potassium flux into the matrix might have on mitochondrial function within the cell.

9.3
Measuring matrix volume in situ
[206]
ATP
ATP
[206]
[97]
ATP
Section 8.2
[97]
[225]
+
 channels.

9.4
Measuring flavoprotein oxidation
+
+
+
[226]
Ca
[227]
[209,228]
ATP
+
[169,229]
[182]
[228,230]
+
Section 9.1
[12]
).


10
+
 channels might protect hearts from ischaemia reperfusion injury?
+
 channels to play a role in preconditioning there would have to be a mechanism by which their opening might be linked to improved recovery. Several possible mechanisms have been proposed.
10.1
Enhanced mitochondrial ATP production
[182,198]
[161,231]
[206]
[206]
ATP
[11]
+
ATP
[232,233]
[232–235]
ATP
[206]
. The more probable determinant of the efficiency of myocardial ATP production during reperfusion is the extent to which the mitochondria are damaged.

10.2
Mild uncoupling leads to less calcium overload and ROS production
+
[12,151,152,162,163,227,236]
+
[169,229]
[228,230]
[232,237,238]
ATP
 channels might cause a minor depolarisation during reperfusion, or slightly reduce the repolarisation, sufficient to reduce ROS formation without having a significant effect on ATP production.
[223,224]
[218–221]
[222]
+
[209–211,239]
[169,206–209,240]
Section 6.4
[218,241]
[224]
[242]
[241]
.

10.3
Production of ROS as a signalling mechanism
[240,243–248]
[249,250]
[12,100,240,245]
ATP
[182,251]
[248]
[11,163,247]
[252]
[182,251]
.
+
[253]
[254]
ATP
[169,206–209,240]
, its is perhaps more likely that their ability to increase ROS is through a direct interaction with a redox centre in one of the respiratory complexes.


11
Other proposed mechanism for inhibiting the permeability transition pore in preconditioning
11.1
The role of connexin 43
[255–258]
[258–260]
2+
[258,259]
Section 6
[261]
[262,263]
[261]
[247]
 and in the latter case the ability of diazoxide to increase ROS was also abolished.
[255–257]
[257]
.
[256]
Fig. 4
[247,261]
[247]
ATP
[255,257]
[257]
[257]
[256]
.

11.2
Transient MPTP opening
[121]
Section 6.1
[264]
[68,75]
[121]
[264]
.


12
Conclusions and future directions
Fig. 5
.
[85,100]
Sections 6
7.1
[99–101]
Section 7.1
[100,101]
Section 7.2
[27,265]
.
[26,28]
Section 6
Section 9.1
[133,266]
[101,135]
[267]
.
[90,91]
[97,107,126]
[268,269]
. Once MPTP opening has occurred during the initial phase of reperfusion, the resulting ROS production would lead to a progressive increase in pore opening in other mitochondria and thus an escalating number of necrotic cells as reflected in the ongoing LDH release and increased infarct size. CsA or SfA will prevent this ongoing opening, but so too might the survival kinase cascades by reducing the ROS production or increasing their removal as described below.
[44]
c
[45]
[72]
c
[70]
[68,98]
c
[270,271]
c
c
c
[272]
[273,274]
[275]
.

Note added in proof
Since submission of this article it has been reported that the properties of the mitochondrial permeability transition pore in mitochondria devoid of all VDAC isoforms are the same as in mitochondria from wild-type mitochondria (C.P. Baines, R.A. Kaiser, T. Sheiko, W.J. Craigen, J.D. Molkentin, Voltage-dependent anion channels are dispensable for mitochondrial-dependent cell death, Nat Cell Biol. 9 (2007) 550–555). This confirms that VDAC is not an essential component of the MPTP.


Acknowledgements
Work from the authors' laboratory has been funded by a Programme Grant from The British Heart Foundation. The authors wish to thank members of the Bristol Heart Institute, and especially Dr. Elinor Griffiths and Professor Saadeh Suleiman, for their continuing encouragement and support, and to Dr. Kate Heesom of The Proteomics Facility for performing the 2D gel electrophoresis.

References
[1]
Halestrap
A.P.

Kerr
P.M.

Javadov
S.

Woodfield
K.Y.


Elucidating the molecular mechanism of the permeability transition pore and its role in reperfusion injury of the heart
Biochim. Biophys. Acta
1998
1366
79
94
9714750


[2]
Suleiman
M.S.

Halestrap
A.P.

Griffiths
E.J.


Mitochondria: a target for myocardial protection
Pharmacol. Ther.
2001
89
29
46
11316512


[3]
Halestrap
A.P.

Clarke
S.J.

Javadov
S.A.


Mitochondrial permeability transition pore opening during myocardial reperfusion—A target for cardioprotection
Cardiovasc. Res.
2004
61
372
385
14962470


[4]
Downey
J.M.

Cohen
M.V.


Reducing infarct size in the setting of acute myocardial infarction
Prog. Cardiovasc. Dis.
2006
48
363
371
16627050


[5]
Fliss
H.

Gattinger
D.


Apoptosis in ischemic and reperfused rat myocardium
Circ. Res.
1996
79
949
956
8888687


[6]
Anversa
P.

Cheng
W.

Liu
Y.

Leri
A.

Redaelli
G.

Kajstura
J.


Apoptosis and myocardial infarction
Basic Res. Cardiol.
1998
93
8
12
9879436


[7]
Shanmuganathan
S.

Hausenloy
D.J.

Duchen
M.R.

Yellon
D.M.


Mitochondrial permeability transition pore as a target for cardioprotection in the human heart
Am. J. Physiol.
2005
289
H237
H242


[8]
Garcia-Dorado
D.

Rodriguez-Sinovas
A.

Ruiz-Meana
M.

Inserte
J.

Agullo
L.

Cabestrero
A.


The end-effectors of preconditioning protection against myocardial cell death secondary to ischemia–reperfusion
Cardiovasc. Res.
2006
70
274
285
16635642


[9]
Halestrap
A.P.


Calcium, mitochondria and reperfusion injury: a pore way to die
Biochem. Soc. Trans.
2006
34
232
237
16545083


[10]
DiLisa
F.

Bernardi
P.


Mitochondria and ischemia–reperfusion injury of the heart: fixing a hole
Cardiovasc. Res.
2006
70
191
199
16497286


[11]
Garlid
K.D.

DosSantos
P.

Xie
Z.J.

Costa
A.D.T.

Paucek
P.


Mitochondrial potassium transport: the role of the mitochondrial ATP-sensitive K+ channel in cardiac function and cardioprotection
Biochim. Biophys. Acta
2003
1606
1
21
14507424


[12]
Hanley
P.J.

Daut
J.


K-ATP channels and preconditioning: a re-examination of the role of mitochondrial KATpchannels and an overview of alternative mechanisms
J. Mol. Cell. Cardiol.
2005
39
17
50
15907927


[13]
Ardehali
H.

O'Rourke
B.


Mitochondrial K-ATP channels in cell survival and death
J. Mol. Cell. Cardiol.
2005
39
7
16
15978901


[14]
Murry
C.E.

Jennings
R.B.

Reimer
K.A.


Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium
Circulation
1986
74
1124
1136
3769170


[15]
Edwards
R.J.

Saurin
A.T.

Rakhit
R.D.

Marber
M.S.


Therapeutic potential of ischaemic preconditioning
Br. J. Clin. Pharmacol.
2000
50
87
97
10930960


[16]
Yellon
D.M.

Downey
J.M.


Preconditioning the myocardium: from cellular physiology to clinical cardiology
Physiol. Rev.
2003
83
1113
1151
14506302


[17]
Kloner
R.A.

Rezkalla
S.H.


Preconditioning, postconditioning and their application to clinical cardiology
Cardiovasc. Res.
2006
70
297
307
16516180


[18]
Liu
Y.

Downey
J.M.


Ischemic preconditioning protects against infarction in rat heart
Am. J. Physiol.
1992
263
H1107
H1112
1415759


[19]
Kimura
Y.

Iyengar
J.

Subramanian
R.

Cordis
G.A.

Das
D.K.


Preconditioning of the heart by repeated stunning: attenuation of post-ischemic dysfunction.
Basic Res. Cardiol.
1992
87
128
138
1590735


[20]
Millar
C.G.

Baxter
G.F.

Thiemermann
C.


Protection of the myocardium by ischaemic preconditioning: mechanisms and therapeutic implications
Pharmacol. Ther.
1996
69
143
151
8984508


[21]
Schwarz
E.R.

Whyte
W.S.

Kloner
R.A.


Ischemic preconditioning
Curr. Opin. Cardiol.
1997
12
475
481
9352175


[22]
Baines
C.P.

Cohen
M.V.

Downey
J.M.


Signal transduction in ischemic preconditioning: the role of kinases and mitochondrial K-ATP channels
J. Cardiovasc. Electrophysiol.
1999
10
741
754
10355930


[23]
Kin
H.

Zhao
Z.Q.

Sun
H.Y.

Wang
N.P.

Corvera
J.S.

Halkos
M.E.

Kerendi
F.

Guyton
R.A.

VintenJohansen
J.


Postconditioning attenuates myocardial ischemia–reperfusion injury by inhibiting events in the early minutes of reperfusion
Cardiovasc. Res.
2004
62
74
85
15023554


[24]
Gateau Roesch
O.

Argaud
L.

Ovize
M.


Mitochondrial permeability transition pore and postconditioning
Cardiovasc. Res.
2006
70
264
273
16581044


[25]
Crisostomo
P.R.

Wairiuko
G.M.

Wang
M.

Tsai
B.M.

Morrell
E.D.

Meldrum
D.R.


Preconditioning versus postconditioning: mechanisms and therapeutic potentials
J. Am. Coll. Surg.
2006
202
797
812
16648020


[26]
Solaini
G.

Harris
D.A.


Biochemical dysfunction in heart mitochondria exposed to ischaemia and reperfusion
Biochem. J.
2005
390
377
394
16108756


[27]
Kevin
L.G.

Camara
A.K.S.

Riess
M.L.

Novalija
E.

Stowe
D.F.


Ischemic preconditioning alters real-time measure of O-2 radicals in intact hearts with ischemia and reperfusion
Am. J. Physiol.
2003
284
H566
H574


[28]
Becker
L.B.


New concepts in reactive oxygen species and cardiovascular reperfusion physiology
Cardiovasc. Res.
2004
61
461
470
14962477


[29]
Pacher
P.

Nivorozhkin
A.

Szabo
C.


Therapeutic effects of xanthine oxidase inhibitors: renaissance half a century after the discovery of allopurinol
Pharmacol. Rev.
2006
58
87
114
16507884


[30]
Zweier
J.L.

Talukder
M.A.H.


The role of oxidants and free radicals in reperfusion injury
Cardiovasc. Res.
2006
70
181
190
16580655


[31]
Chen
Q.

Moghaddas
S.

Hoppel
C.L.

Lesnefsky
E.J.


Reversible blockade of electron transport during ischemia protects mitochondria and decreases myocardial injury following reperfusion
J. Pharmacol. Exp. Ther.
2006
319
1405
1412
16990510


[32]
Silverman
H.S.

Stern
M.D.


Ionic basis of ischaemic cardiac injury: insights from cellular studies
Cardiovasc. Res.
1994
28
581
597
8025901


[33]
Eaton
P.

Byers
H.L.

Leeds
N.

Ward
M.A.

Shattock
M.J.


Detection, quantitation, purification, and identification of cardiac proteins S-thiolated during ischemia and reperfusion
J. Biol. Chem.
2002
277
9806
9811
11777920


[34]
Inagaki
K.

Begley
R.

Ikeno
F.

Mochly-Rosen
D.


Cardioprotection by epsilon-protein kinase C activation from ischemia: continuous delivery and antiarrhythmic effect of an epsilon-protein kinase C-activating peptide
Circulation
2005
111
44
50
15611364


[35]
Hool
L.C.


Reactive oxygen species in cardiac signalling: from mitochondria to plasma membrane ion channels
Clin. Exp. Pharmacol. Physiol.
2006
33
146
151
16445714


[36]
Petrosillo
G.

Ruggiero
F.M.

DiVenosa
N.

Paradies
G.


Decreased complex III activity in mitochondria isolated from rat heart subjected to ischemia and reperfusion: role of reactive oxygen species and cardiolipin
FASEB J.
2003
17
U395
U413


[37]
Paradies
G.

Petrosillo
G.

Pistolese
M.

DiVenosa
N.

Federici
A.

Ruggiero
F.M.


Decrease in mitochondrial complex I activity in ischemic/reperfused rat heart—Involvement of reactive oxygen species and cardiolipin
Circ. Res.
2004
94
53
59
14656928


[38]
Echtay
K.S.

Esteves
T.C.

Pakay
J.L.

Jekabsons
M.B.

Lambert
A.J.

PorteroOtin
M.

Pamplona
R.

VidalPuig
A.J.

Wang
S.

Roebuck
S.J.

Brand
M.D.


A signalling role for 4-hydroxy-2-nonenal in regulation of mitochondrial uncoupling
EMBO J.
2003
22
4103
4110
12912909


[39]
Garcia Dorado
D.

Rodniguez Sinovas
A.

Ruiz Meana
M.

Inserte
J.

Agullo
L.

Cabestrero
A.


The end-effectors of preconditioning protection against myocardial cell death secondary to ischemia–reperfusion
Cardiovasc. Res.
2006
70
274
285
16635642


[40]
Halestrap
A.P.

McStay
G.P.

Clarke
S.J.


The permeability transition pore complex: another view
Biochimie
2002
84
153
166
12022946


[41]
Bernardi
P.

Krauskopf
A.

Basso
E.

Petronilli
V.

BlalchyDyson
E.

DiLisa
F.

Forte
M.A.


The mitochondrial permeability transition from in vitro artifact to disease target
FEBS J.
2006
273
2077
2099
16649987


[42]
Scorrano
L.

Petronilli
V.

Bernardi
P.


On the voltage dependence of the mitochondrial permeability transition pore—A critical appraisal
J. Biol. Chem.
1997
272
12295
12299
9139672


[43]
Bernardi
P.


Mitochondrial transport of cations: channels, exchangers, and permeability transition
Physiol. Rev.
1999
79
1127
1155
10508231


[44]
Doran
E.

Halestrap
A.P.


Cytochrome c release from isolated rat liver mitochondria can occur independently of outer-membrane rupture: possible role of contact sites
Biochem. J.
2000
348
343
350
10816428


[45]
Martinou
J.C.

Green
D.R.


Breaking the mitochondrial barrier
Nat. Rev., Mol. Cell Biol.
2001
2
63
67
11413467


[46]
Halestrap
A.


A pore way to die
Nature
2005
434
578
579
15800609


[47]
Waldmeier
P.C.

Zimmermann
K.

Qian
T.

TintelnotBlomley
M.

Lemasters
J.J.


Cyclophilin D as a drug target
Curr. Med. Chem.
2003
10
1485
1506
12871122


[48]
Crompton
M.

Ellinger
H.

Costi
A.


Inhibition by cyclosporin A of a Ca2+-dependent pore in heart mitochondria activated by inorganic phosphate and oxidative stress
Biochem. J.
1988
255
357
360
3196322


[49]
Halestrap
A.P.

Davidson
A.M.


Inhibition of Ca2+-induced large amplitude swelling of liver and heart mitochondria by Cyclosporin A is probably caused by the inhibitor binding to mitochondrial matrix peptidyl-prolyl cis-trans isomerase and preventing it interacting with the adenine nucleotide translocase
Biochem. J.
1990
268
153
160
2160810


[50]
Griffiths
E.J.

Halestrap
A.P.


Further evidence that cyclosporin-A protects mitochondria from calcium overload by inhibiting a matrix peptidyl-prolyl cis-trans isomerase—Implications for the immunosuppressive and toxic effects of cyclosporin
Biochem. J.
1991
274
611
614
1706598


[51]
Connern
C.P.

Halestrap
A.P.


Purification and N-terminal sequencing of peptidyl-prolyl cis-trans-isomerase from rat liver mitochondrial matrix reveals the existence of a distinct mitochondrial cyclophilin
Biochem. J.
1992
284
381
385
1599421


[52]
Woodfield
K.Y.

Price
N.T.

Halestrap
A.P.


cDNA cloning of rat mitochondrial cyclophilin
Biochim. Biophys. Acta
1997
1351
27
30
9116040


[53]
Basso
E.

Fante
L.

Fowlkes
J.

Petronilli
V.

Forte
M.A.

Bernardi
P.


Properties of the permeability transition pore in mitochondria devoid of cyclophilin D
J. Biol. Chem.
2005
280
18558
18561
15792954


[54]
Nakagawa
T.

Shimizu
S.

Watanabe
T.

Yamaguchi
O.

Otsu
K.

Yamagata
H.

Inohara
H.

Kubo
T.

Tsujimoto
Y.


Cyclophilin D-dependent mitochondrial permeability transition regulates some necrotic but not apoptotic cell death
Nature
2005
434
652
658
15800626


[55]
Baines
C.P.

Kaiser
R.A.

Purcell
N.H.

Blair
N.S.

Osinska
H.

Hambleton
M.A.

Brunskill
E.W.

Sayen
M.R.

Gottlieb
R.A.

Dorn
G.W.

Robbins
J.

Molkentin
J.D.


Loss of cyclophilin D reveals a critical role for mitochondrial permeability transition in cell death
Nature
2005
434
658
662
15800627


[56]
Halestrap
A.P.

Brenner
C.


The adenine nucleotide translocase: A central component of the mitochondrial permeability transition pore and key player in cell death
Curr. Med. Chem.
2003
10
1507
1525
12871123


[57]
Halestrap
A.P.

Woodfield
K.Y.

Connern
C.P.


Oxidative stress, thiol reagents, and membrane potential modulate the mitochondrial permeability transition by affecting nucleotide binding to the adenine nucleotide translocase
J. Biol. Chem.
1997
272
3346
3354
9013575


[58]
McStay
G.P.

Clarke
S.J.

Halestrap
A.P.


Role of critical thiol groups on the matrix surface of the adenine nucleotide translocase in the mechanism of the mitochondrial permeability transition pore
Biochem. J.
2002
367
541
548
12149099


[59]
Woodfield
K.

Ruck
A.

Brdiczka
D.

Halestrap
A.P.


Direct demonstration of a specific interaction between cyclophilin-D and the adenine nucleotide translocase confirms their role in the mitochondrial permeability transition
Biochem. J.
1998
336
287
290
9820802


[60]
Brustovetsky
N.

Klingenberg
M.


Mitochondrial ADP/ATP carrier can be reversibly converted into a large channel by Ca2+
Biochemistry
1996
35
8483
8488
8679608


[61]
Brustovetsky
N.

Tropschug
M.

Heimpel
S.

Heidkamper
D.

Klingenberg
M.


A large Ca2+-dependent channel formed by recombinant ADP/ATP carrier from Neurospora crassa resembles the mitochondrial permeability transition pore
Biochemistry
2002
41
11804
11811
12269823


[62]
Kokoszka
J.E.

Waymire
K.G.

Levy
S.E.

Sligh
J.E.

Cal
J.Y.

Jones
D.P.

MacGregor
G.R.

Wallace
D.C.


The ADP/ATP translocator is not essential for the mitochondrial permeability transition pore
Nature
2004
427
461
465
14749836


[63]
Halestrap
A.P.


Dual role for the ADP/ATP translocator?
Nature
2004
430
U1


[64]
He
L.

Lemasters
J.J.


Regulated and unregulated mitochondrial permeability transition pores: a new paradigm of pore structure and function?
FEBS Lett.
2002
512
1
7
11852041


[65]
Crompton
M.


The mitochondrial permeability transition pore and its role in cell death
Biochem. J.
1999
341
233
249
10393078


[66]
Cesura
A.M.

Pinard
E.

Schubenel
R.

Goetschy
V.

Friedlein
A.

Langen
H.

Polcic
P.

Forte
M.A.

Bernardi
P.

Kemp
J.A.


The voltage-dependent anion channel is the target for a new class of inhibitors of the mitochondrial permeability transition pore
J. Biol. Chem.
2003
278
49812
49818
12952973


[67]
Krauskopf
A.

Eriksson
O.

Craigen
W.J.

Forte
M.A.

Bernardi
P.


Properties of the permeability transition in VDAC1(−/−) mitochondria
Biochim. Biophys. Acta
2006
1757
590
595
16626625


[68]
Griffiths
E.J.

Halestrap
A.P.


Mitochondrial non-specific pores remain closed during cardiac ischaemia, but open upon reperfusion
Biochem. J.
1995
307
93
98
7717999


[69]
Hausenloy
D.J.

Yellon
D.M.

Mani-Babu
S.

Duchen
M.R.


Preconditioning protects by inhibiting the mitochondrial permeability transition
Am. J. Physiol.
2004
287
H841
H849


[70]
Borutaite
V.

Budriunaite
A.

Morkuniene
R.

Brown
G.C.


Release of mitochondrial cytochrome c and activation of cytosolic caspases induced by myocardial ischaemia
Biochim. Biophys. Acta
2001
1537
101
109
11566253


[71]
Borutaite
V.

Jekabsone
A.

Morkuniene
R.

Brown
G.C.


Inhibition of mitochondrial permeability transition prevents mitochondrial dysfunction, cytochrome c release and apoptosis induced by heart ischemia
J. Mol. Cell. Cardiol.
2003
35
357
366
12689815


[72]
Capano
M.

Crompton
M.


Bax translocates to mitochondria of heart cells during simulated ischaemia: involvement of AMP-activated and p38 mitogen-activated protein kinases
Biochem. J.
2006
395
57
64
16321138


[73]
Kim
J.S.

Jin
Y.G.

Lemasters
J.J.


Reactive oxygen species, but not Ca2+ overloading, trigger pH- and mitochondrial permeability transition-dependent death of adult rat myocytes after ischemia–reperfusion
Am. J. Physiol.
2006
290
H2024
H2034


[74]
Halestrap
A.P.


Calcium-dependent opening of a non-specific pore in the mitochondrial inner membrane is inhibited at pH values below 7—Implications for the protective effect of low pH against chemical and hypoxic cell damage
Biochem. J.
1991
278
715
719
1654889


[75]
Kerr
P.M.

Suleiman
M.S.

Halestrap
A.P.


Reversal of permeability transition during recovery of hearts from ischemia and its enhancement by pyruvate
Am. J. Physiol.
1999
276
H496
H502
9950850


[76]
Bond
J.M.

Herman
B.

Lemasters
J.J.


Protection by acidotic pH against anoxia reoxygenation injury to rat neonatal cardiac myocytes
Biochem. Biophys. Res. Commun.
1991
179
798
803
1898402


[77]
Bond
J.M.

Chacon
E.

Herman
B.

Lemasters
J.J.


Intracellular pH and Ca2+ homeostasis in the pH paradox of reperfusion injury to neonatal rat cardiac myocytes
Am. J. Physiol.
1993
265
C129
C137
8338121


[78]
Bond
J.M.

Harper
I.S.

Chacon
E.

Reece
J.M.

Herman
B.

Lemasters
J.J.


The pH paradox in the pathophysiology of reperfusion injury to rat neonatal cardiac myocytes
Ann. N. Y. Acad. Sci.
1994
723
24
37


[79]
Allen
D.G.

Xiao
X.H.


Role of the cardiac Na+/H+ exchanger during ischemia and reperfusion
Cardiovasc. Res.
2003
57
934
941
12650871


[80]
Javadov
S.

Huang
C.

Kirshenbaum
L.

Karmazyn
M.


NHE-1 inhibition improves impaired mitochondrial permeability transition and respiratory function during postinfarction remodelling in the rat
J. Mol. Cell. Cardiol.
2005
38
135
143
15623430


[81]
Fujita
M.

Asanuma
H.

Hirata
A.

Wakeno
M.

Takahama
H.

Sasaki
H.

Kim
J.

Takashima
S.

Tsukamoto
O.

Minamino
T.

Shinozaki
Y.

Tomoike
H.

Hori
M.

Kitakaze
M.


Prolonged transient acidosis during early reperfusion contributes to the cardioprotective effects of postconditioning
Am. J. Physiol.
2007
292
H2004
H2008


[82]
Cohen
M.V.

Yang
X.M.

Downey
J.M.


The pH hypothesis of postconditioning: staccato reperfusion reintroduces oxygen and perpetuates myocardial acidosis
Circulation
2007
115
1895
1903
17389262


[83]
Miyata
H.

Lakatta
E.G.

Stern
M.D.

Silverman
H.S.


Relation of mitochondrial and cytosolic free calcium to cardiac myocyte recovery after exposure to anoxia
Circ. Res.
1992
71
605
613
1499108


[84]
VandenHoek
T.L.

Becker
L.B.

Shao
Z.H.

Li
C.Q.

Schumacker
P.T.


Preconditioning in cardiomyocytes protects by attenuating oxidant stress at reperfusion
Circ. Res.
2000
86
541
548
10720416


[85]
Javadov
S.A.

Clarke
S.

Das
M.

Griffiths
E.J.

Lim
K.H.H.

Halestrap
A.P.


Ischaemic preconditioning inhibits opening of mitochondrial permeability transition pores in the reperfused rat heart
J. Physiol.
2003
549
513
524
12692185


[86]
Griffiths
E.J.

Halestrap
A.P.


Protection by cyclosporin A of ischemia reperfusion-induced damage in isolated rat hearts
J. Mol. Cell. Cardiol.
1993
25
1461
1469
7512654


[87]
DiLisa
F.

Menabo
R.

Canton
M.

Barile
M.

Bernardi
P.


Opening of the mitochondrial permeability transition pore causes depletion of mitochondrial and cytosolic NAD(+) and is a causative event in the death of myocytes in postischemic reperfusion of the heart
J. Biol. Chem.
2001
276
2571
2575
11073947


[88]
Clarke
S.J.

McStay
G.P.

Halestrap
A.P.


Sanglifehrin A acts as a potent inhibitor of the mitochondrial permeability transition and reperfusion injury of the heart by binding to cyclophilin-D at a different site from cyclosporin A
J. Biol. Chem.
2002
277
34793
34799
12095984


[89]
Argaud
L.

Gateau-Roesch
O.

Muntean
D.

Chalabreysse
L.

Loufouat
J.

Robert
D.

Ovize
M.


Specific inhibition of the mitochondrial permeability transition prevents lethal reperfusion injury
J. Mol. Cell. Cardiol.
2005
38
367
374
15698843


[90]
Hausenloy
D.J.

Maddock
H.L.

Baxter
G.F.

Yellon
D.M.


Inhibiting mitochondrial permeability transition pore opening: a new paradigm for myocardial preconditioning?
Cardiovasc. Res.
2002
55
534
543
12160950


[91]
Hausenloy
D.J.

Duchen
M.R.

Yellon
D.M.


Inhibiting mitochondrial permeability transition pore opening at reperfusion protects against ischaemia–reperfusion injury
Cardiovasc. Res.
2003
60
617
625
14659807


[92]
Javadov
S.A.

Lim
K.H.H.

Kerr
P.M.

Suleiman
M.S.

Angelini
G.D.

Halestrap
A.P.


Protection of hearts from reperfusion injury by propofol is associated with inhibition of the mitochondrial permeability transition
Cardiovasc. Res.
2000
45
360
369
10728356


[93]
Lim
K.H.H.

Halestrap
A.P.

Angelini
G.D.

Suleiman
M.S.


Propofol is cardioprotective in a clinically relevant model of normothermic blood cardioplegic arrest and cardiopulmonary bypass
Exp. Biol. Med.
2005
230
413
420


[94]
Mentzer
R.M.

Lasley
R.D.

Jessel
A.

Karmazyn
M.


Intracellular sodium hydrogen exchange inhibition and clinical myocardial protection
Ann. Thorac. Surg.
2003
75
S700
S708
12607715


[95]
Mallet
R.T.

Sun
J.

Knott
E.M.

Sharma
A.B.

Olivencia-Yurvati
A.H.


Metabolic cardioprotection by pyruvate: recent progress
Exp. Biol. Med.
2005
230
435
443


[96]
Mallet
R.T.


Pyruvate: metabolic protector of cardiac performance
Proc. Soc. Exp. Biol. Med.
2000
223
136
148
10654616


[97]
Juhaszova
M.

Zorov
D.B.

Kim
S.H.

Pepe
S.

Fu
Q.

Fishbein
K.W.

Ziman
B.D.

Wang
S.

Ytrehus
K.

Antos
C.L.

Olson
E.N.

Sollott
S.J.


Glycogen synthase kinase-3 beta mediates convergence of protection signaling to inhibit the mitochondrial permeability transition pore
J. Clin. Invest.
2004
113
1535
1549
15173880


[98]
Matsumoto-Ida
M.

Akao
M.

Takeda
T.

Kato
M.

Kita
T.


Real-time 2-photon imaging of mitochondrial function in perfused rat hearts subjected to ischemia/reperfusion
Circulation
2006
114
1497
1503
17000908


[99]
Argaud
L.

GateauRoesch
O.

Chalabreysse
L.

Gomez
L.

Loufouat
J.

ThivoletBejui
F.

Robert
D.

Ovize
M.


Preconditioning delays Ca2+-induced mitochondrial permeability transition
Cardiovasc. Res.
2004
61
115
122
14732208


[100]
Khaliulin
I.

Schwalb
H.

Wang
P.

Houminer
E.

Grinberg
L.

Katzeff
H.

Borman
J.B.

Powell
S.R.


Preconditioning improves postischemic mitochondrial function and diminishes oxidation of mitochondrial proteins
Free Radical Biol. Med.
2004
37
1
9
15183190


[101]
Khaliulin
I.

Clarke
S.J.

Lin
H.

Parker
J.

Suleiman
M.S.

Halestrap
A.P.


Temperature preconditioning of isolated rat hearts—A potent cardioprotective mechanism involving a reduction in oxidative stress and inhibition of the mitochondrial permeability transition pore
J. Physiol.
2007
581
1147
1161
17395631


[102]
Argaud
L.

GateauRoesch
O.

Raisky
O.

Loufouat
J.

Robert
D.

Ovize
M.


Postconditioning inhibits mitochondrial permeability transition
Circulation
2005
111
194
197
15642769


[103]
Armstrong
S.C.


Protein kinase activation and myocardial ischemia/reperfusion injury
Cardiovasc. Res.
2004
61
427
436
14962474


[104]
Gross
E.R.

Gross
G.J.


Ligand triggers of classical preconditioning and postconditioning
Cardiovasc. Res.
2006
70
212
221
16448635


[105]
Inagaki
K.

Churchill
E.

Mochly Rosen
D.


Epsilon protein kinase C as a potential therapeutic target for the ischemic heart
Cardiovasc. Res.
2006
70
222
230
16635641


[106]
Cohen
M.V.

Yang
X.M.

Downey
J.M.


Nitric oxide is a preconditioning mimetic and cardioprotectant and is the basis of many available infarct-sparing strategies
Cardiovasc. Res.
2006
70
231
239
16376869


[107]
Hausenloy
D.J.

Yellon
D.M.


Survival kinases in ischemic preconditioning and postconditioning
Cardiovasc. Res.
2006
70
240
253
16545352


[108]
Saurin
A.T.

Pennington
D.J.

Raat
N.J.

Latchman
D.S.

Owen
M.J.

Marber
M.S.


Targeted disruption of the protein kinase C epsilon gene abolishes the infarct size reduction that follows ischaemic preconditioning of isolated buffer-perfused mouse hearts
Cardiovasc. Res.
2002
55
672
680
12160964


[109]
Cross
H.R.

Murphy
E.

Bolli
R.

Ping
P.

Steenbergen
C.


Expression of activated PKC epsilon (PKC epsilon) protects the ischemic heart, without attenuating ischemic H(+) production
J. Mol. Cell. Cardiol.
2002
34
361
367
11945027


[110]
Ping
P.

Song
C.

Zhang
J.

Guo
Y.

Cao
X.

Li
R.C.

Wu
W.

Vondriska
T.M.

Pass
J.M.

Tang
X.L.

Pierce
W.M.

Bolli
R.


Formation of protein kinase C(epsilon)-Lck signaling modules confers cardioprotection
J. Clin. Invest.
2002
109
499
507
11854322


[111]
Inagaki
K.

Chen
L.

Ikeno
F.

Lee
F.H.

Imahashi
K.

Bouley
D.M.

Rezaee
M.

Yock
P.G.

Murphy
E.

MochlyRosen
D.


Inhibition of delta-protein kinase C protects against reperfusion injury of the ischemic heart in vivo
Circulation
2003
108
2304
2307
14597593


[112]
Mitchell
M.B.

Meng
X.

Ao
L.

Brown
J.M.

Harken
A.H.

Banerjee
A.


Preconditioning of isolated rat heart is mediated by protein kinase C
Circ. Res.
1995
76
73
81
8001280


[113]
Ping
P.

Zhang
J.

Qiu
Y.

Tang
X.L.

Manchikalapudi
S.

Cao
X.

Bolli
R.


Ischemic preconditioning induces selective translocation of protein kinase C isoforms and in the heart of conscious rabbits without subcellular redistribution of total protein kinase C activity
Circ. Res.
1997
81
404
414
9285643


[114]
Baines
C.P.

Zhang
J.

Wang
G.W.

Zheng
Y.T.

Xiu
J.X.

Cardwell
E.M.

Bolli
R.

Ping
P.


Mitochondrial PKC epsilon and MAPK form signaling modules in the murine heart—Enhanced mitochondrial PKC epsilon–MAPK interactions and differential MAPK activation in PKC epsilon-induced cardioprotection
Circ. Res.
2002
90
390
397
11884367


[115]
Baines
C.P.

Song
C.X.

Zheng
Y.T.

Wang
G.W.

Zhang
J.

Wang
O.L.

Guo
Y.

Bolli
R.

Cardwell
E.M.

Ping
P.P.


Protein kinase C epsilon interacts with and inhibits the permeability transition pore in cardiac mitochondria
Circ. Res.
2003
92
873
880
12663490


[116]
Simonis
G.

Weinbrenner
C.

Strasser
R.H.


Ischemic preconditioning promotes a transient, but not sustained translocation of protein kinase C and sensitization of adenylyl cyclase
Basic Res. Cardiol.
2003
98
104
113
12607132


[117]
VandenHoek
T.L.

Becker
L.B.

Shao
Z.H.

Li
C.Q.

Schumacker
P.T.


Reactive oxygen species released from mitochondria during brief hypoxia induce preconditioning in cardiomyocytes
J. Biol. Chem.
1998
273
18092
18098
9660766


[118]
Baines
C.P.

Goto
M.

Downey
J.M.


Oxygen radicals released during ischemic preconditioning contribute to cardioprotection in the rabbit myocardium
J. Mol. Cell. Cardiol.
1997
29
207
216
9040035


[119]
Novalija
E.

Kevin
L.G.

Eells
J.T.

Henry
M.M.

Stowe
D.F.


Anesthetic preconditioning improves adenosine triphosphate synthesis and reduces reactive oxygen species formation in mitochondria after ischemia by a redox dependent mechanism
Anesthesiology
2003
98
1155
1163
12717137


[120]
Bouwman
R.A.

Musters
R.J.

van Beek-Harmsen
B.J.

de Lange
J.J.

Boer
C.


Reactive oxygen species precede protein kinase C-delta activation independent of adenosine triphosphate-sensitive mitochondrial channel opening in sevoflurane-induced cardioprotection.
Anesthesiology
2004
100
506
514
15108962


[121]
Hausenloy
D.

Wynne
A.

Duchen
M.

Yellon
D.


Transient mitochondrial permeability transition pore opening mediates preconditioning-induced protection
Circulation
2004
109
1714
1717
15066952


[122]
Korichneva
I.

Hoyos
B.

Chua
R.

Levi
E.

Hammerling
U.


Zinc release from protein kinase C as the common event during activation by lipid second messenger or reactive oxygen
J. Biol. Chem.
2002
277
44327
44331
12213816


[123]
Costa
A.D.T.

Garlid
K.D.

West
I.C.

Lincoln
T.M.

Downey
J.M.

Cohen
M.V.

Critz
S.D.


Protein kinase G transmits the cardioprotective signal from cytosol to mitochondria
Circ. Res.
2005
97
329
336
16037573


[124]
Jones
S.P.

Bolli
R.


The ubiquitous role of nitric oxide in cardioprotection
J. Mol. Cell. Cardiol.
2006
40
16
23
16288777


[125]
Costa
A.D.

Jakob
R.

Costa
C.L.

Andrukhiv
K.

West
I.C.

Garlid
K.D.


The mechanism by which the mitochondrial ATP-sensitive K+ channel opening and H2O2 inhibit the mitochondrial permeability transition
J. Biol. Chem.
2006
281
20801
20808
16720572


[126]
Hausenloy
D.J.

Tsang
A.

Mocanu
M.M.

Yellon
D.M.


Ischemic preconditioning protects by activating prosurvival kinases at reperfusion
Am. J. Physiol.
2005
288
H971
H976


[127]
Mocanu
M.M.

Yellon
D.M.


PTEN, the Achilles' heel of myocardial ischaemia/reperfusion injury?
Br. J. Pharmacol.
2007
150
833
838
17293884


[128]
Hausenloy
D.J.

Mocanu
M.A.

Yellon
D.M.


Cross-talk between the survival kinases during early reperfusion: its contribution to ischemic preconditioning
Cardiovasc. Res.
2004
63
305
312
15249188


[129]
Tsang
A.

Hausenloy
D.J.

Mocanu
M.M.

Carr
R.D.

Yellon
D.M.


Preconditioning the diabetic heart—The importance of Akt phosphorylation
Diabetes
2005
54
2360
2364
16046302


[130]
Davidson
S.M.

Hausenloy
D.

Duchen
M.R.

Yellon
D.M.


Signalling via the reperfusion injury signalling kinase (RISK) pathway links closure of the mitochondrial permeability transition pore to cardioprotection
Int. J. Biochem. Cell Biol.
2006
38
414
419
16280253


[131]
Jope
R.S.

Johnson
G.V.W.


The glamour and gloom of glycogen synthase kinase-3
Trends Biochem. Sci.
2004
29
95
102
15102436


[132]
Pastorino
J.G.

Hoek
J.B.

Shulga
N.


Activation of glycogen synthase kinase 3beta disrupts the binding of hexokinase II to mitochondria by phosphorylating voltage-dependent anion channel and potentiates chemotherapy-induced cytotoxicity
Cancer Res.
2005
65
10545
10554
16288047


[133]
Young
L.H.

Li
J.

Baron
S.J.

Russell
R.R.


AMP-Activated protein kinase: a key stress signaling pathway in the heart
Trends Cardiovasc. Med.
2005
15
110
118
16039971


[134]
Russell
R.R.

Li
J.

Coven
D.L.

Pypaert
M.

Zechner
C.

Palmeri
M.

Giordano
F.J.

Mu
J.

Birnbaum
M.J.

Young
L.H.


AMP-activated protein kinase mediates ischemic glucose uptake and prevents postischemic cardiac dysfunction, apoptosis, and injury
J. Clin. Invest.
2004
114
495
503
15314686


[135]
Sukhodub
A.

Jovanovic
S.

Du
Q.

Budas
G.

Clelland
A.K.

Shen
M.

Sakamoto
K.

Tian
R.

Jovanovic
A.


AMP-activated protein kinase mediates preconditioning in cardiomyocytes by regulating activity and trafficking of sarcolemmal ATP-sensitive K(+) channels
J. Cell. Physiol.
2007
210
224
236
17044064


[136]
Nishino
Y.

Miura
T.

Miki
T.

Sakamoto
J.

Nakamura
Y.

Ikeda
Y.

Kobayashi
H.

Shimamoto
K.


Ischemic preconditioning activates AMPK in a PKC-dependent manner and induces GLUT4 up-regulation in the late phase of cardioprotection
Cardiovasc. Res.
2004
61
610
619
14962491


[137]
Kim
J.S.

Ohshima
S.

Pediaditakis
P.

Lemasters
J.J.


Nitric oxide protects rat hepatocytes against reperfusion injury mediated by the mitochondrial permeability transition
Hepatology
2004
39
1533
1543
15185294


[138]
Hughes
W.A.

Halestrap
A.P.


The regulation of branched-chain 2-oxoacid dehydrogenase of liver, kidney and heart by phosphorylation
Biochem. J.
1981
196
459
469
7316988


[139]
Armston
A.E.

Halestrap
A.P.

Scott
R.D.


The nature of the changes in liver mitochondrial function induced by glucagon treatment of rats.The effects of intramitochondrial volume,aging and benzyl alcohol
Biochim. Biophys. Acta
1982
681
429
439
7126557


[140]
Hughes
B.P.

Barritt
G.J.


Effects of glucagon and N6O2′-dibutyryladenosine 3′5′-cyclic monophosphate on calcium transport in isolated rat liver mitochondria
Biochem. J.
1978
176
295
304
215132


[141]
Prpic
V.

Spencer
T.L.

Bygrave
F.L.


Stable enhancement of calcium retention in mitochondria isolated from rat liver after the administration of glucagon to the intact animal
Biochem. J.
1978
176
705
714
747647


[142]
Horbinski
C.

Chu
C.T.


Kinase signaling cascades in the mitochondrion: a matter of life or death
Free Radical Biol. Med.
2005
38
2
11
15589366


[143]
Pagliarini
D.J.

Dixon
J.E.


Mitochondrial modulation: reversible phosphorylation takes center stage?
Trends Biochem. Sci.
2006
31
26
34
16337125


[144]
Vargas
A.

Halestrap
A.P.

Denton
R.M.


The effects of glucagon, phenylephrine and insulin on thephosphorylation of cytoplasmic, mitochondrial and membrane-bound proteins of intact liver cells from starved rats
Biochem. J.
1982
208
221
229
6760856


[145]
Schulenberg
B.

Aggeler
R.

Beechem
J.M.

Capaldi
R.A.

Patton
W.F.


Analysis of steady-state protein phosphorylation in mitochondria using a novel fluorescent phosphosensor dye
J. Biol. Chem.
2003
278
27251
27255
12759343


[146]
Gumina
R.

O'cochlain
D.

Kurtz
C.

Bast
P.

Pucar
D.

Mishra
P.

Miki
T.

Seino
S.

Macura
S.

Terzic
A.


KATP channel knockout worsens myocardial calcium stress-load in vivo and impairs recovery in stunned heart
Am. J. Physiol.
2007
92
H1706
H1713


[147]
Griffiths
E.J.

Ocampo
C.J.

Savage
J.S.

Rutter
G.A.

Hansford
R.G.

Stern
M.D.

Silverman
H.S.


Mitochondrial calcium transporting pathways during hypoxia and reoxygenation in single rat cardiomyocytes
Cardiovasc. Res.
1998
39
423
433
9798527


[148]
Narayan
P.

Mentzer
R.M.

Lasley
R.D.


Adenosine A1 receptor activation reduces reactive oxygen species and attenuates stunning in ventricular myocytes
J. Mol. Cell. Cardiol.
2001
33
121
129
11133228


[149]
Ozcan
C.

Bienengraeber
M.

Dzeja
P.P.

Terzic
A.


Potassium channel openers protect cardiac mitochondria by attenuating oxidant stress at reoxygenation
Am. J. Physiol.
2002
282
H531
H539


[150]
Ylitalo
K.V.

AlaRami
A.

Liimatta
E.V.

Peuhkurinen
K.J.

Hassinen
I.E.


Intracellular free calcium and mitochondrial membrane potential in ischemia/reperfusion and preconditioning
J. Mol. Cell. Cardiol.
2000
32
1223
1238
10860765


[151]
Wang
L.G.

Cherednichenko
G.

Hernandez
L.

Halow
J.

Camacho
S.A.

Figueredo
V.

Schaefer
S.


Preconditioning limits mitochondrial Ca2+ during ischemia in rat hearts: role of K-ATP channels
Am. J. Physiol.
2001
280
H2321
H2328


[152]
Murata
M.

Akao
M.

O'Rourke
B.

Marban
E.


Mitochondrial ATP-sensitive potassium channels attenuate matrix Ca2+ overload during simulated ischemia and reperfusion—Possible mechanism of cardioprotection
Circ. Res.
2001
89
891
898
11701616


[153]
Schulz
R.

Cohen
M.V.

Behrends
M.

Downey
J.M.

Heusch
G.


Signal transduction of ischemic preconditioning
Cardiovasc. Res.
2001
52
181
198
11684066


[154]
Powell
S.R.

Gurzenda
E.M.

Wahezi
S.E.


Actin is oxidized during myocardial ischaemia
Free Radical Biol. Med.
2001
30
1171
1176
11369508


[155]
Valen
G.

Starkopf
J.

Takeshima
S.

Kullisaar
T.

Vihalemm
T.

Kengsepp
A.T.

Lowbeer
C.

Vaage
J.

Zilmer
M.


Preconditioning with hydrogen peroxide (H2O2) or ischemia in H2O2-induced cardiac dysfunction
Free Radical Res.
1998
29
235
245
9802555


[156]
Morihira
M.

Hasebe
N.

Baljinnyam
E.

Sumitomo
K.

Matsusaka
T.

Izawa
K.

Fujino
T.

Fukuzawa
J.

Kikuchi
K.


Ischemic preconditioning enhances scavenging activity of reactive oxygen species and diminishes transmural difference of infarct size
Am. J. Physiol.
2006
290
H577
H583


[157]
Kane
G.C.

Liu
X.K.

Yamada
S.

Olson
T.M.

Terzic
A.


Cardiac K-ATP channels in health and disease
J. Mol. Cell. Cardiol.
2005
38
937
943
15910878


[158]
Suzuki
M.

Sasaki
N.

Miki
T.

Sakamoto
N.

Ohmoto Sekine
Y.

Tamagawa
M.

Seino
S.

Marban
E.

Nakaya
H.


Role of sarcolemmal K-ATP channels in cardioprotection against ischemia/reperfusion injury in mice
J. Clin. Invest.
2002
109
509
516
11854323


[159]
Suzuki
M.

Saito
T.

Sato
T.

Tamagawa
M.

Miki
T.

Seino
S.

Nakaya
H.


Cardioprotective effect of diazoxide is mediated by activation of sarcolemmal but not mitochondrial ATP-sensitive potassium channels in mice
Circulation
2003
107
682
685
12578868


[160]
Gumina
R.J.

Pucar
D.

Bast
P.

Hodgson
D.M.

Kurtz
C.E.

Dzeja
P.P.

Miki
T.

Seino
S.

Terzic
A.


Knockout of Kir6.2 negates ischemic preconditioning-induced protection of myocardial energetics
Am. J. Physiol.
2003
284
H2106
H2113


[161]
Grover
G.J.

Garlid
K.D.


ATP-sensitive potassium channels: a review of their cardioprotective pharmacology
J. Mol. Cell. Cardiol
2000
32
677
695
10756123


[162]
Oldenburg
O.

Cohen
M.V.

Downey
J.M.


Mitochondrial K-ATP channels in preconditioning
J. Mol. Cell. Cardiol.
2003
35
569
575
12788373


[163]
O'Rourke
B.


Evidence for mitochondrial K+ channels and their role in cardioprotection
Circ. Res.
2004
94
420
432
15001541


[164]
Brierley
G.P.

Baysal
K.

Jung
D.W.


Cation transport systems in mitochondria: Na+ and K+ uniports and exchangers
J. Bioenerg. Biomembranes
1994
26
519
526


[165]
Garlid
K.D.

Paucek
P.


Mitochondrial potassium transport: the K+ cycle
Biochim. Biophys. Acta
2003
1606
23
41
14507425


[166]
Szewczyk
A.

Skalska
J.

Glab
M.

Kulawiak
B.

Malinska
D.

Koszela-Piotrowska
I.

Kunz
W.S.


Mitochondrial potassium channels: from pharmacology to function
Biochim. Biophys. Acta
2006
1757
715
720
16787636


[167]
Jaburek
M.

YarovYarovoy
V.

Paucek
P.

Garlid
K.D.


State-dependent inhibition of the mitochondrial K-ATP channel by glyburide and 5-hydroxydecanoate
J. Biol. Chem.
1998
273
13578
13582
9593694


[168]
Garlid
K.D.

Paucek
P.

Yarovyarovoy
V.

Sun
X.C.

Schindler
P.A.


The mitochondrial K-ATP channel as a receptor for potassium channel openers
J. Biol. Chem.
1996
271
8796
8799
8621517


[169]
Kowaltowski
A.J.

Seetharaman
S.

Paucek
P.

Garlid
K.D.


Bioenergetic consequences of opening the ATP-sensitive K+ channel of heart mitochondria
Am. J. Physiol.
2001
280
H649
H657


[170]
Das
M.

Parker
J.E.

Halestrap
A.P.


Matrix volume measurements challenge the existence of diazoxide/glibencamide-sensitive K-ATP channels in rat mitochondria
J. Physiol.
2003
547
893
902
12562892


[171]
Brustovetsky
T.

Shalbuyeva
N.

Brustovetsky
N.


Lack of manifestations of diazoxide/5-hydroxydecanoatesensitive K-ATP channel in rat brain nonsynaptosomal mitochondria
J. Physiol.
2005
568
47
59
16051627


[172]
Inoue
I.

Nagase
H.

Kishi
K.

Higuti
T.


ATP-sensitive K+ channel in the mitochondrial inner membrane
Nature
1991
352
244
247
1857420


[173]
Siemen
D.

Loupatatzis
C.

Borecky
J.

Gulbins
E.

Lang
F.


Ca2+-activated K channel of the BK-type in the inner mitochondrial membrane of a human glioma cell line
Biochem. Biophys. Res. Commun.
1999
257
549
554
10198249


[174]
Xu
W.H.

Liu
Y.G.

Wang
S.

McDonald
T.

VanEyk
J.E.

Sidor
A.

ORourke
B.


Cytoprotective role of Ca2+-activated K+ channels in the cardiac inner mitochondrial membrane
Science
2002
298
1029
1033
12411707


[175]
YarovYarovoy
V.

Paucek
P.

Jaburek
M.

Garlid
K.D.


The nucleotide regulatory sites on the mitochondrial K-ATP channel face the cytosol
Biochim. Biophys. Acta
1997
1321
128
136
9332501


[176]
Paucek
P.

Mironova
G.

Mahdi
F.

Beavis
A.D.

Woldegiorgis
G.

Garlid
K.D.


Reconstitution and Partial Purification of the glibenclamide-sensitive, ATP-dependent K+-channel from rat liver and beef heart mitochondria
J. Biol. Chem.
1992
267
26062
26069
1464617


[177]
Paucek
P.

YarovYarovoy
V.

Sun
X.C.

Garlid
K.D.


Inhibition of the mitochondrial K-ATP channel by long-chain Acyl-CoA esters and activation by guanine nucleotides
J. Biol. Chem.
1996
271
32084
32088
8943260


[178]
Bednarczyk
P.

Kicinska
A.

Kominkova
V.

Ondrias
K.

Dolowy
K.

Szewczyk
A.


Quinine inhibits mitochondrial ATP-regulated potassium channel from bovine heart
J. Membr. Biol.
2004
199
63
72
15383917


[179]
Bednarezyk
P.

Dolowy
K.

Szewczyk
A.


Matrix Mg2+ regulates mitochondrial ATP-dependent potassium channel from heart
FEBS Lett.
2005
579
1625
1632
15757652


[180]
Halestrap
A.P.


The regulation of the oxidation of fatty acids and other substrates in rat heart mitochondria by changes in matrix volume induced by osmotic strength, valinomycin and Ca2+
Biochem. J.
1987
244
159
164
3663110


[181]
Whipps
D.E.

Armston
A.E.

Pryor
H.J.

Halestrap
A.P.


Effects of glucagon and Ca2+ on the metabolism of phosphatidylinositol-4-phosphate and phosphatidylinositol-4,5-bisphosphate in isolated rat hepatocytes and plasma membranes
Biochem. J.
1987
241
835
845
3036077


[182]
Halestrap
A.P.


The regulation of the matrix volume of mammalian mitochondria in vivo and in vitro, and its role in the control of mitochondrial metabolism
Biochim. Biophys. Acta
1989
973
355
382
2647140


[183]
Stoner
C.D.

Sirak
H.D.


Adenine nucleotide-induced contraction on the inner mitochondrial membrane. II. Effect of bongkrekic acid
J. Cell Biol.
1973
56
65
73
4345167


[184]
Stoner
C.D.

Sirak
H.D.


Adenine nucleotide-induced contraction of the inner mitochondrial membrane. I. General characterization
J. Cell Biol.
1973
56
51
64
4345166


[185]
Klingenberg
M.


The ADP-ATP translocation in mitochondria, a membrane potential controlled transport
J. Membr. Biol.
1980
56
97
105
7003152


[186]
Davidson
A.M.

Halestrap
A.P.


Liver mitochondrial pyrophosphate concentration is increased by Ca2+ and regulates the intramitochondrial volume and adenine nucleotide content
Biochem. J.
1987
246
715
723
2825649


[187]
Halestrap
A.P.

Davidson
A.M.


The role of the adenine nucleotide transporter in the regulation ofintramitochondrial volume
Azzi
A.

Fonyo
A.

Nalecz
M.J.

Vignais
P.V.

Wojtcak
L.


Anion Carriers of mitochondrial membranes
1989
Springer Verlag
Berlin
337
348


[188]
Panov
A.

Filippova
S.

Lyakhovich
V.


Adenine nucleotide translocase as a site of regulation by ADP of the rat liver mitochondrial permeability to H+ and K+ ions
Arch. Biochem. Biophys.
1980
199
420
426
6244779


[189]
Beavis
A.D.

Lu
Y.

Garlid
K.D.


On the regulation of K+ uniport in intact mitochondria by adenine nucleotides and nucleotide analogs
J. Biol. Chem.
1993
268
997
1004
8380420


[190]
Garlid
K.D.

Paucek
P.

Yarov Yarovoy
V.

Murray
H.N.

Darbenzio
R.B.

DAlonzo
A.J.

Lodge
N.J.

Smith
M.A.

Grover
G.J.


Cardioprotective effect of diazoxide and its interaction with mitochondrial ATP-Sensitive K+ channels—Possible mechanism of cardioprotection
Circ. Res.
1997
81
1072
1082
9400389


[191]
Dhahan
N.

Moreau
C.

Prost
A.L.

Jacquet
H.

Alekseev
A.E.

Terzic
A.

Vivaudou
M.


Pharmacological plasticity of cardiac ATP-sensitive potassium channels toward diazoxide revealed by ADP
Proc. Natl. Acad. Sci. U. S. A.
1999
96
12162
12167
10518593


[192]
Suzuki
M.

Saito
T.

Sato
T.

Tamagawa
M.

Miki
T.

Seino
S.

Nakaya
H.


Cardioprotective effect of diazoxide is mediated by activation of sarcolemmal but not mitochondrial ATP-sensitive potassium channels in mice — Response
Circulation
2003
108
E44
12912801


[193]
Liu
Y.G.

Ren
G.F.

O'Rourke
B.

Marban
E.

Seharaseyon
J.


Pharmacological comparison of native mitochondrial K-ATP channels with molecularly defined surface K-ATP channels
Mol. Pharmacol.
2001
59
225
230
11160857


[194]
Notsu
T.

Ohhashi
K.

Tanaka
I.

Ishikawa
H.

Niho
T.

Fukutake
K.

Mizota
M.


5-Hydroxydecanoate inhibits ATP-sensitive K+ channel currents in guinea-pig single ventricular myocytes
Eur. J. Pharmacol.
1992
220
35
41
1425978


[195]
Lacza
Z.

Snipes
J.A.

Miller
A.W.

Szabo
C.

Grover
G.

Busija
D.W.


Heart mitochondria contain functional ATP-dependent K+ channels
J. Mol. Cell. Cardiol.
2003
35
1339
1347
14596790


[196]
Singh
H.

Hudman
D.

Lawrence
C.L.

Rainbow
R.D.

Lodwick
D.

Norman
R.I.


Distribution of Kir6.0 and SUR2 ATP-sensitive potassium channel subunits in isolated ventricular myocytes
J. Mol. Cell. Cardiol.
2003
35
445
459
12738227


[197]
Bajgar
R.

Seetharaman
S.

Kowaltowski
A.J.

Garlid
K.D.

Paucek
P.


Identification and properties of a novel intracellular (Mitochondrial) ATP-sensitive potassium channel in brain
J. Biol. Chem.
2001
276
33369
33374
11441006


[198]
Halestrap
A.P.


Regulation of mitochondrial metabolism through changes in matrix volume
Biochem. Soc. Trans.
1994
22
522
529
7958359


[199]
Krämer
R.


Characterisation of pyrophosphate exchange by the reconstituted adenine nucleotide translocator from mitochondria
Biochem. Biophys. Res. Commun.
1985
127
129
135
2983704


[200]
Asimakis
G.K.

Aprille
J.R.


In vitro alteration of the size of the liver mitochondrial adenine nucleotide pool, correlation with respiratory functions
Arch. Biochem. Biophys.
1980
203
307
316
7406502


[201]
D'Souza
M.P.

Wilson
D.F.


Adenine dincucleotide efflux in mitochondria induced by inorganic pyrophosphate
Biochim. Biophys. Acta
1982
680
28
32
6280763


[202]
Jung
D.W.

Brierley
G.P.


The permeability of uncoupled heart mitochondria to potassium ion
J. Biol. Chem.
1984
259
6904
6911
6202687


[203]
Jung
D.W.

Brierley
G.P.


On the relationship between the uncoupler-induced efflux of K+ from heart mitochondria and the oxidation–reduction state of pyridine nucleotides
J. Biol. Chem.
1981
256
10490
10496
6169721


[204]
Griffiths
E.J.

Halestrap
A.P.


Pyrophosphate metabolism in the perfused heart and isolated heart mitochondria and its role in regulation of mitochondrial function by calcium
Biochem. J.
1993
290
489
495
8383966


[205]
Grover
G.J.

Murray
H.N.

Baird
A.J.

Dzwonczyk
S.


The KATP blocker sodium 5-hydroxydecanoate does not abolish preconditioning in isolated rat hearts
Eur. J. Pharmacol.
1995
277
271
274
7493619


[206]
Lim
K.H.H.

Javadov
S.A.

Das
M.

Clarke
S.J.

Suleiman
M.S.

Halestrap
A.P.


The effects of ischaemic preconditioning, diazoxide and 5-hydroxydecanoate on rat heart mitochondrial volume and respiration
J. Physiol.
2002
545
961
974
12482899


[207]
Schafer
G.

Portenhauser
R.

Trolp
R.


Inhibition of mitochondrial metabolism by the diabetogenic thiadiazine diazoxide. I. Action on succinate dehydrogenase and TCA-cycle oxidations
Biochem. Pharmacol.
1971
20
1271
1280
5118123


[208]
Grimmsman
T.

Rustenbeck
I.


Direct effects of diazoxide on mitochondria in pancreatic B-cells and on isolated liver mitochondria
Br. J. Pharmacol.
1998
123
781
788
9535004


[209]
Hanley
P.J.

Mickel
M.

Loffler
M.

Brandt
U.

Daut
J.


K-ATP channel-independent targets of diazoxide and 5-hydroxydecanoate in the heart
J. Physiol.
2002
542
735
741
12154175


[210]
Kopustinskiene
D.M.

Toleikis
A.

Saris
N.E.L.


Adenine nucleotide translocase mediates the K-ATP-channel-openers-induced proton and potassium flux to the mitochondrial matrix
J. Bioenerg. Biomembr.
2003
35
141
148
12887012


[211]
Holmuhamedov
E.L.

Jahangir
A.

Oberlin
A.

Komarov
A.

Colombini
M.

Terzic
A.


Potassium channel openers are uncoupling protonophores: implication in cardioprotection
FEBS Lett.
2004
568
167
170
15196941


[212]
Ziemys
A.

Toleikis
A.

Kopustinskiene
D.M.


Molecular modelling of K(ATP) channel blockers—ADP/ ATP carrier interactions
Syst. Biol.
2006
153
390
393


[213]
Hanley
P.J.

Gopalan
K.V.

Lareau
R.A.

Srivastava
D.K.

von Meltzer
M.

Daut
J.


beta-oxidation of 5-hydroxydecanoate, a putative blocker of mitochondrial ATP-sensitive potassium channels
J. Physiol.
2003
547
387
393
12562916


[214]
Hanley
P.J.

Drose
S.

Brandt
U.

Lareau
R.A.

Banerjee
A.L.

Srivastava
D.K.

Banaszak
L.J.

Barycki
J.J.

VanVeldhoven
P.P.

Daut
J.


5-Hydroxydecanoate is metabolised in mitochondria and creates a rate-limiting bottleneck for beta-oxidation of fatty acids
J. Physiol.
2005
562
307
318
15513944


[215]
Cook
D.E.

Blair
J.B.

Lardy
H.A.


Mode of action of hypoglycaemic agents. V. Studies with phenylethylbiguanide in isolated perfused rat liver
J. Biol. Chem.
1973
248
5272
5277
4768899


[216]
Cook
G.A.


The hypoglycemic sulfonylureas glyburide and tolbutamide inhibit fatty acid oxidation by inhibiting carnitine palmitoyltransferase
J. Biol. Chem.
1987
262
4968
4972
3104327


[217]
Lehtihet
M.

Welsh
N.

Berggren
P.O.

Cook
G.A.

Sjoholm
A.


Glibenclamide inhibits islet carnitine palmitoyltransferase 1 activity, leading to PKC-dependent insulin exocytosis
Am. J. Physiol.
2003
285
E438
E446


[218]
Kabir
A.M.

Cao
X.

Gorog
D.A.

Tanno
M.

Bassi
R.

Bellahcene
M.

Quinlan
R.A.

Davis
R.J.

Flavell
R.A.

Shattock
M.J.

Marber
M.S.


Antimycin A induced cardioprotection is dependent on pre-ischemic p38-MAPK activation but independent of MKK3
J. Mol. Cell. Cardiol.
2005
39
709
717
16140323


[219]
Chen
Q.

Camara
A.K.

Stowe
D.F.

Hoppel
C.L.

Lesnefsky
E.J.


Modulation of electron transport protects cardiac mitochondria and decreases myocardial injury during ischemia and reperfusion
Am. J. Physiol.
2007
292
C137
C147


[220]
Chen
Q.

Hoppel
C.L.

Lesnefsky
E.J.


Blockade of electron transport before cardiac ischemia with the reversible inhibitor amobarbital protects rat heart mitochondria
J. Pharmacol. Exp. Ther.
2006
316
200
207
16174799


[221]
Lesnefsky
E.J.

Chen
Q.

Moghaddas
S.

Hassan
M.O.

Tandler
B.

Hoppel
C.L.


Blockade of electron transport during ischemia protects cardiac mitochondria
J. Biol. Chem.
2004
279
47961
47967
15347666


[222]
Ockaili
R.A.

Bhargava
P.

Kukreja
R.C.


Chemical preconditioning with 3-nitropropionic acid in hearts: role of mitochondrial K-ATP channel
Am. J. Physiol.
2001
280
H2406
H2411


[223]
Brennan
J.P.

Berry
R.G.

Baghai
M.

Duchen
M.R.

Shattock
M.J.


FCCP is cardioprotective at concentrations that cause mitochondrial oxidation without detectable depolarisation
Cardiovasc. Res.
2006
72
322
330
16979603


[224]
Brennan
J.P.

Southworth
R.

Medina
R.A.

Davidson
S.M.

Duchen
M.R.

Shattock
M.J.


Mitochondrial uncoupling, with low concentration FCCP, induces ROS-dependent cardioprotection independent of KATP channel activation
Cardiovasc. Res.
2006
72
313
321
16950237


[225]
Connern
C.P.

Halestrap
A.P.


Chaotropic agents and increased matrix volume enhance binding of mitochondrial cyclophilin to the inner mitochondrial membrane and sensitize the mitochondrial permeability transition to [Ca2+]
Biochemistry
1996
35
8172
8180
8679570


[226]
Liu
Y.G.

Sato
T.

ORourke
B.

Marban
E.


Mitochondrial ATP-dependent potassium channels: Novel effectors of cardioprotection?
Circulation
1998
97
2463
2469
9641699


[227]
Sato
T.

Saito
T.

Saegusa
N.

Nakaya
H.


Mitochondrial Ca2+-activated K+ channels in cardiac myocytes—A mechanism of the cardioprotective effect and modulation by protein kinase A
Circulation
2005
111
198
203
15623543


[228]
Lawrence
C.L.

Billups
B.

Rodrigo
G.C.

Standen
N.B.


The K-ATP channel opener diazoxide protects cardiac myocytes during metabolic inhibition without causing mitochondrial depolarization or flavoprotein oxidation
Br. J. Pharmacol.
2001
134
535
542
11588107


[229]
Garlid
K.D.


Opening mitochondrial K-ATP in the heart—What happens, and what does not happen
Basic Res. Cardiol.
2000
95
275
279
11005581


[230]
Carroll
R.

Gant
V.A.

Yellon
D.M.


Mitochondrial K-ATP channel opening protects a human atrial-derived cell line by a mechanism involving free radical generation
Cardiovasc. Res.
2001
51
691
700
11530102


[231]
O’Rourke
B.


Myocardial K-ATP channels in preconditioning
Circ. Res.
2000
87
845
855
11073879


[232]
Hassinen
I.E.

Vuorinen
K.H.

Ylitalo
K.

AlaRami
A.


Role of cellular energetics in ischemia–reperfusion and ischemic preconditioning of myocardium
Mol. Cell. Biochem.
1998
184
393
400
9746333


[233]
AlaRami
A.

Ylitalo
K.V.

Hassinen
I.E.


Ischaemic preconditioning and a mitochondrial K-ATP channel opener both produce cardioprotection accompanied by F1F0-ATPase inhibition in early ischaemia
Basic Res. Cardiol.
2003
98
250
258
12835954


[234]
Kolocassides
K.G.

Galinanes
M.

Hearse
D.J.


Preconditioning accelerates contracture and ATP depletion in blood-perfused rat hearts
Am. J. Physiol.
1995
38
H1415
H1420
7485575


[235]
Kolocassides
K.G.

Seymour
A.M.

Galinanes
M.

Hearse
D.J.


Paradoxical effect of ischemic preconditioning on ischemic contracture? NMR studies of energy metabolism and intracellular pH in the rat heart
J. Mol. Cell. Cardiol.
1996
28
1045
1057
8762042


[236]
Holmuhamedov
E.L.

Wang
L.W.

Terzic
A.


ATP-sensitive K+ channel openers prevent Ca2+ overload in rat cardiac mitochondria
J. Physiol.
1999
519
347
360
10457054


[237]
Cave
A.C.

Garlick
P.B.


Ischemic preconditioning and intracellular pH: A P-31 NMR study in the isolated rat heart
Am. J. Physiol.
1997
41
H544
H552
9038977


[238]
Pucar
D.

Dzeja
P.P.

Bast
P.

Juranic
N.

Macura
S.

Terzic
A.


Cellular energetics in the preconditioned state—Protective role for phosphotransfer reactions captured by O-18-assisted P-31 NMR
J. Biol. Chem.
2001
276
44812
44819
11583991


[239]
Kopustinskiene
D.M.

Jovaisiene
J.

Liobikas
J.

Toleikis
A.


Diazoxide and pinacidil uncouple pyruvate-malate-induced mitochondrial respiration
J. Bioenerg. Biomembr.
2002
34
49
53
11860180


[240]
Minners
J.

Lacerda
L.

Yellon
D.M.

Opie
L.H.

McLeod
C.J.

Sack
M.N.


Diazoxide-induced respiratory inhibition—A putative mitochondrial K(ATP) channel independent mechanism of pharmacological preconditioning
Mol. Cell. Biochem.
2007
294
11
18
17136444


[241]
Kabir
A.M.

Clark
J.E.

Tanno
M.

Cao
X.

Hothersall
J.S.

Dashnyam
S.

Gorog
D.A.

Bellahcene
M.

Shattock
M.J.

Marber
M.S.


Cardioprotection initiated by reactive oxygen species is dependent on activation of PKCepsilon
Am. J. Physiol.
2006
291
H1893
H1899


[242]
Miwa
S.

Brand
M.D.


Mitochondrial matrix reactive oxygen species production is very sensitive to mild uncoupling
Biochem. Soc. Trans.
2003
31
1300
1301
14641047


[243]
Pain
T.

Yang
X.M.

Critz
S.D.

Yue
Y.

Nakano
A.

Liu
G.S.

Heusch
G.

Cohen
M.V.

Downey
J.M.


Opening of mitochondrial K-ATP channels triggers the preconditioned state by generating free radicals
Circ. Res.
2000
87
460
466
10988237


[244]
Patel
H.

Gross
G.J.


Diazoxide induced cardioprotection: what comes first, KATP channels or reactive oxygen species?
Cardiovasc. Res.
2001
51
633
636
11530096


[245]
Forbes
R.A.

Steenbergen
C.

Murphy
E.


Diazoxide-induced cardioprotection requires signaling through a redox-sensitive mechanism
Circ. Res.
2001
88
802
809
11325872


[246]
Oldenburg
O.

Yang
X.M.

Krieg
T.

Garlid
K.D.

Cohen
M.V.

Grover
G.J.

Downey
J.M.


P1075 opens mitochondrial K-ATP channels and generates reactive oxygen species resulting in cardioprotection of rabbit hearts
J. Mol. Cell. Cardiol.
2003
35
1035
1042
12967626


[247]
Heinzel
F.R.

Luo
Y.K.

Li
X.K.

Boengler
K.

Buechert
A.

Garcia Dorado
D.

DiLisa
F.

Schulz
R.

Heusch
G.


Impairment of diazoxide-induced formation of reactive oxygen species and loss of cardioprotection in Connexin 43 deficient mice
Circ. Res.
2005
97
583
586
16100048


[248]
Andrukhiv
A.

Costa
A.D.

West
I.C.

Garlid
K.D.


Opening mitoKATP increases superoxide generation from Complex I of the electron transport chain
Am. J. Physiol.
2006
291
H2067
H2074


[249]
Facundo
H.T.F.

Carreira
R.S.

de Paula
J.G.

Santos
C.C.X.

Ferranti
R.

Laurindo
F.R.M.

Kowaltowski
A.J.


Ischemic preconditioning requires increases in reactive oxygen release independent of mitochondrial K+ channel activity
Free Radical Biol. Med.
2006
40
469
479
16443162


[250]
Dzeja
P.P.

Bast
P.

Ozcan
C.

Valverde
A.

Holmuhamedov
E.L.

VanWylen
D.G.L.

Terzic
A.


Targeting nucleotide-requiring enzymes: implications for diazoxide-induced cardioprotection
Am. J. Physiol.
2003
284
H1048
H1056


[251]
Halestrap
A.P.


Role of cell volume changes in metabolic regulation: Regulation of mitochondrial metabolism through changes in matrix volume
Biochem. Soc. Trans.
1994
22
522
529
7958359


[252]
Oldenburg
O.

Cohen
M.V.

Yellon
D.M.

Downey
J.M.


Mitochondrial K-ATP channels: role in cardioprotection
Cardiovasc. Res.
2002
55
429
437
12160940


[253]
Costa
A.D.T.

Quinlan
C.L.

Andrukhiv
A.

West
I.C.

Jaburek
M.

Garlid
K.D.


The direct physiological effects of mitoK(ATP) opening on heart mitochondria
Am. J. Physiol.
2006
290
H406
H415


[254]
Lambert
A.J.

Brand
M.D.


Superoxide production by NADH: ubiquinone oxidoreductase (Complex I) depends on the pH gradient across the mitochondrial inner membrane
Biochem. J.
2004
382
511
517
15175007


[255]
Boengler
K.

Dodoni
G.

RodriguezSinovas
A.

Cabestrero
A.

RuizMeana
M.

Gres
P.

Konietzka
I.

LopezIglesias
C.

GarciaDorado
D.

DiLisa
F.

Heusch
G.

Schulz
R.


Connexin 43 in cardiomyocyte mitochondria and its increase by ischemic preconditioning
Cardiovasc. Res.
2005
67
234
244
15919068


[256]
Halestrap
A.P.


Mitochondria and preconditioning: a connexin connection?
Circ. Res.
2006
99
10
12
16825585


[257]
Rodriguez-Sinovas
A.

Boengler
K.

Cabestrero
A.

Gres
P.

Morente
M.

RuizMeana
M.

Konietzka
I.

Miro
E.

Totzeck
A.

Heusch
G.

Schulz
R.

Garcia-Dorado
D.


Translocation of connexin 43 to the inner mitochondrial membrane of cardiomyocytes through the heat shock protein 90-dependent TOM pathway and its importance for cardioprotection
Circ. Res.
2006
99
93
101
16741159


[258]
Schulz
R.

Heusch
G.


Connexin43 and ischemic preconditioning
Adv. Cardiol.
2006
42
213
227
16646593


[259]
Schulz
R.

Heusch
G.


Connexin 43 and ischemic preconditioning
Cardiovasc. Res.
2004
62
335
344
15094353


[260]
Dhein
S.


New, emerging roles for cardiac connexins. Mitochondrial Cx43 raises new questions
Cardiovasc. Res.
2005
67
179
181
15979055


[261]
Schwanke
U.

Konietzka
I.

Duschin
A.

Li
X.K.

Schulz
R.

Heusch
G.


No ischemic preconditioning in heterozygous connexin43-deficient mice
Am. J. Physiol.
2002
283
H1740
H1742


[262]
Schulz
R.

Gres
P.

Skyschally
A.

Duschin
A.

Belosjorow
S.

Konietzka
I.

Heusch
G.


Ischemic preconditioning preserves connexin 43 phosphorylation during sustained ischemia in pig hearts in vivo
FASEB J.
2003
17
U147
U168


[263]
Jain
S.K.

Schuessler
R.B.

Saffitz
J.E.


Mechanisms of delayed electrical uncoupling induced by ischemic preconditioning
Circ. Res.
2003
92
1138
1144
12730093


[264]
Halestrap
A.P.


Does the mitochondrial permeability transition have a role in preconditioning?
Circulation
2004
110
E303
15364824


[265]
Stowe
D.F.

Riess
M.L.


Reactive oxygen species and cardiac preconditioning: Many questions remain
Cardiovasc. Drugs Ther.
2004
18
87
90
15293369


[266]
Kahn
B.B.

Alquier
T.

Carling
D.

Hardie
D.G.


AMP-activated protein kinase: ancient energy gauge provides clues to modern understanding of metabolism
Cell Metab.
2005
1
15
25
16054041


[267]
Peralta
C.

Bartrons
R.A.

Serafin
A.

Blazquez
C.

Guzman
M.

Prats
N.

Xaus
C.

Cutillas
B.

Gelpi
E.

RoselloCatafau
J.


Adenosine monophosphate-activated protein kinase mediates the protective effects of ischemic preconditioning on hepatic ischemia–reperfusion injury in the rat
Hepatology
2001
34
1164
1173
11732006


[268]
Zorov
D.B.

Filburn
C.R.

Klotz
L.O.

Zweier
J.L.

Sollott
S.J.


Reactive oxygen species (ROS)-induced ROS release: A new phenomenon accompanying induction of the mitochondrial permeability transition in cardiac myocytes
J. Exp. Med.
2000
192
1001
1014
11015441


[269]
Zorov
D.B.

Juhaszova
M.

Sollott
S.J.


Mitochondrial ROS-induced ROS release: an update and review
Biochim. Biophys. Acta
2006
1757
509
517
16829228


[270]
Ricci
J.E.

Gottlieb
R.A.

Green
D.R.


Caspase-mediated loss of mitochondrial function and generation of reactive oxygen species during apoptosis
J. Cell Biol.
2003
160
65
75
12515825


[271]
Ricci
J.E.

MunozPinedo
C.

Fitzgerald
P.

BaillyMaitre
B.

Perkins
G.A.

Yadava
N.

Scheffler
I.E.

Ellisman
M.H.

Green
D.R.


Disruption of mitochondrial function during apoptosis is mediated by caspase cleavage of the p75 subunit of complex I of the electron transport chain
Cell
2004
117
773
786
15186778


[272]
Kennedy
S.G.

Kandel
E.S.

Cross
T.K.

Hay
N.


Akt protein kinase B inhibits cell death by preventing the release of cytochrome c from mitochondria
Mol. Cell. Biol.
1999
19
5800
5810
10409766


[273]
Datta
S.R.

Dudek
H.

Tao
X.

Masters
S.

Fu
H.A.

Gotoh
Y.

Greenberg
M.E.


Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery
Cell
1997
91
231
241
9346240


[274]
Datta
S.R.

Katsov
A.

Hu
L.

Petros
A.

Fesik
S.W.

Yaffe
M.B.

Greenberg
M.E.


14-3-3 proteins and survival kinases cooperate to inactivate BAD by BH3 domain phosphorylation
Mol. Cell
2000
6
41
51
10949026


[275]
Maurer
U.

Charvet
C.

Wagman
A.S.

Dejardin
E.

Green
D.R.


Glycogen synthase kinase-3 regulates mitochondrial outer membrane permeabilization and apoptosis by destabilization of MCL-1
Mol. Cell
2006
21
749
760
16543145




Fig. 1
[72]
[89]
g
 for 5 min) were included (Hom) as were samples of the membrane fraction (Slm—primarily sarcolemma) removed by Percoll density gradient centrifugation. Western blotting was performed using antibodies against total and phosphorylated forms of AMPK, GSK3β and Akt, as well as MCT1, ANT and glyceraldehyde-3-phosphate dehydrogenase (GAPDH) as markers for sarcolemma, mitochondria and cytosol. Data shown are previously unpublished data of the authors.



Fig. 2
Fig. 1
[138]
.



Fig. 3
ATP
[160]
3
2
14
[165]
+
 movements across the inner mitochondrial membrane.



Fig. 4
Figs. 1 and
2
g
[255]
. Panel B shows the data (mean ± S.E.M.) from 6 separate experiments in which the Cx43 and ANT blots were scanned and the Cx43 band intensity expressed as a ratio with respect to the ANT band intensity for mitochondrial and particulate fractions.



Fig. 5
ATP
 channel openers and other factors that perturb mitochondrial function may lead to inhibition of MPTP opening during reperfusion. The proposed scheme is based on the evidence and reasoning presented in the text. Boxes shaded pastel blue represent the preconditioning stimuli, whilst pastel green represent components of potential signalling pathways and pastel pink the effects on the mitochondrial target. The blue box signifies the effects of any process that perturbs mitochondrial function such as through mild inhibition of respiratory chain complexes or uncoupling. The red circle and question mark that links PKC to diminished ROS levels at the end of ischaemia and during reperfusion target represent a critical step in preconditioning whose mechanism is unknown and requires elucidation.





